Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Are Higher Doses of Consolidation Radiation Therapy Necessary in Diffuse Large B-cell Lymphoma Involving Osseous Sites?

Lee JW, Prosnitz LR, Stefanovic A, Kelsey CR.

Adv Radiat Oncol. 2019 Mar 30;4(3):507-512. doi: 10.1016/j.adro.2019.03.010. eCollection 2019 Jul-Sep.

2.

Phase 2 Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-Cell Lymphoma.

Kelsey CR, Broadwater G, James O, Chino J, Diehl L, Beaven AW, Chang C, Koontz BF, Prosnitz LR.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):96-101. doi: 10.1016/j.ijrobp.2019.02.055. Epub 2019 Mar 8.

PMID:
30858144
3.

Chemotherapy or Combined Modality Therapy for Early-stage Hodgkin Lymphoma.

Torok JA, Wu Y, Chino J, Prosnitz LR, Beaven AW, Kim GJ, Kelsey CR.

Anticancer Res. 2018 May;38(5):2875-2881.

PMID:
29715111
4.

Consolidation Radiation Therapy for Patients With Advanced Hodgkin Lymphoma in Complete Metabolic Response According to PET-CT or Gallium Imaging.

Song EJ, Torok J, Wu Y, Chino J, Prosnitz LR, Beaven AW, Kelsey CR.

Clin Lymphoma Myeloma Leuk. 2018 Feb;18(2):145-151. doi: 10.1016/j.clml.2017.12.007. Epub 2017 Dec 30.

PMID:
29358045
5.

Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.

Torok JA, Wu Y, Prosnitz LR, Kim GJ, Beaven AW, Diehl LF, Kelsey CR.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):54-9. doi: 10.1016/j.ijrobp.2015.02.003.

PMID:
25863754
6.

Improving outcomes in advanced DLBCL: systemic approaches and radiotherapy.

Boyle J, Beaven AW, Diehl LF, Prosnitz LR, Kelsey CR.

Oncology (Williston Park). 2014 Dec;28(12):1074-81, 1084.

7.

Reducing local therapy in patients responding to preoperative systemic therapy: are we outsmarting ourselves?

Marks LB, Prosnitz LR.

J Clin Oncol. 2014 Feb 20;32(6):491-3. doi: 10.1200/JCO.2013.51.3523. Epub 2013 Dec 30. No abstract available.

PMID:
24378409
8.

Low-dose whole brain radiotherapy combined with radiosurgery for primary CNS lymphoma achieving partial response to induction methotrexate-based chemotherapy.

Oh DS, Vredenburgh JA, Reardon DA, Prosnitz LR, Gockerman JP, Sampson JH, Kelsey CR, Kirkpatrick JP.

J Radiosurg SBRT. 2014;3(1):37-42.

9.

Combined-modality therapy for early-stage Hodgkin lymphoma: maintaining high cure rates while minimizing risks.

Kelsey CR, Beaven AW, Diehl LF, Prosnitz LR.

Oncology (Williston Park). 2012 Dec;26(12):1182-9, 1193. Review.

10.

Validating a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer.

Cheng SH, Tsai SY, Yu BL, Horng CF, Chen CM, Jian JJ, Chu NM, Tsou MH, Liu MC, Huang AT, Prosnitz LR.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):953-8. doi: 10.1016/j.ijrobp.2012.08.042. Epub 2012 Nov 1.

PMID:
23122982
11.

Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update.

Westermann A, Mella O, Van Der Zee J, Jones EL, Van Der Steen-Banasik E, Koper P, Uitterhoeve AL, De Wit R, Van Der Velden J, Burger C, Schem BC, Van Der Wilt C, Dahl O, Prosnitz LR, Van Tinteren H.

Int J Hyperthermia. 2012;28(6):549-53. doi: 10.3109/02656736.2012.673047. Epub 2012 Jul 13.

PMID:
22788973
12.

Radiotherapy dose-response analysis for diffuse large B-cell lymphoma with a complete response to chemotherapy.

Dorth JA, Prosnitz LR, Broadwater G, Beaven AW, Kelsey CR.

Radiat Oncol. 2012 Jun 21;7:100. doi: 10.1186/1748-717X-7-100.

13.

Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging.

Dorth JA, Prosnitz LR, Broadwater G, Diehl LF, Beaven AW, Coleman RE, Kelsey CR.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):762-7. doi: 10.1016/j.ijrobp.2011.12.067. Epub 2012 Mar 13.

PMID:
22420972
14.

Breast conservation therapy: the influence of molecular subtype and margins.

Demirci S, Broadwater G, Marks LB, Clough R, Prosnitz LR.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):814-20. doi: 10.1016/j.ijrobp.2011.09.001. Epub 2011 Dec 28.

PMID:
22208971
15.

Radiation therapy in the management of diffuse large B-cell lymphoma: still relevant?

Kelsey CR, Beaven AW, Diehl LF, Prosnitz LR.

Oncology (Williston Park). 2010 Nov 30;24(13):1204-12.

16.

Preoperative single fraction partial breast radiotherapy for early-stage breast cancer.

Palta M, Yoo S, Adamson JD, Prosnitz LR, Horton JK.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):37-42. doi: 10.1016/j.ijrobp.2010.09.041. Epub 2010 Nov 17.

PMID:
21093166
17.

Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy.

Zagar TM, Higgins KA, Miles EF, Vujaskovic Z, Dewhirst MW, Clough RW, Prosnitz LR, Jones EL.

Radiother Oncol. 2010 Dec;97(3):535-40. doi: 10.1016/j.radonc.2010.10.020. Epub 2010 Nov 11.

18.

Hyperthermia for locally advanced breast cancer.

Zagar TM, Oleson JR, Vujaskovic Z, Dewhirst MW, Craciunescu OI, Blackwell KL, Prosnitz LR, Jones EL.

Int J Hyperthermia. 2010;26(7):618-24. doi: 10.3109/02656736.2010.501051. Review.

19.

Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data.

Zagar TM, Oleson JR, Vujaskovic Z, Dewhirst MW, Craciunescu OI, Blackwell KL, Prosnitz LR, Jones EL.

Int J Hyperthermia. 2010;26(7):612-7. doi: 10.3109/02656736.2010.487194. Review.

20.

The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans.

Dorth JA, Chino JP, Prosnitz LR, Diehl LF, Beaven AW, Coleman RE, Kelsey CR.

Ann Oncol. 2011 Feb;22(2):405-10. doi: 10.1093/annonc/mdq389. Epub 2010 Jul 30.

PMID:
20675560
21.

Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082.

Marks LB, Cirrincione C, Fitzgerald TJ, Laurie F, Glicksman AS, Vredenburgh J, Prosnitz LR, Shpall EJ, Crump M, Richardson PG, Schuster MW, Ma J, Peterson BL, Norton L, Seagren S, Henderson IC, Hurd DD, Peters WP; Cancer and Leukemia Group B; Southwest Oncology Group; National Cancer Institute of Canada Clinical Trials Group.

Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1305-13. doi: 10.1016/j.ijrobp.2009.04.013. Epub 2009 Sep 9.

22.

DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: a pilot study.

Craciunescu OI, Blackwell KL, Jones EL, Macfall JR, Yu D, Vujaskovic Z, Wong TZ, Liotcheva V, Rosen EL, Prosnitz LR, Samulski TV, Dewhirst MW.

Int J Hyperthermia. 2009;25(6):405-15. doi: 10.1080/02656730903022700.

23.

Accelerated partial breast irradiation: caution and concern from an ASTRO task force.

Prosnitz LR, Horton J, Wallner PE.

Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):981-4. doi: 10.1016/j.ijrobp.2009.03.046. No abstract available.

PMID:
19545782
24.

One to three versus four or more positive nodes and postmastectomy radiotherapy: time to end the debate.

Marks LB, Zeng J, Prosnitz LR.

J Clin Oncol. 2008 May 1;26(13):2075-7. doi: 10.1200/JCO.2007.15.5200. No abstract available.

PMID:
18445836
25.

Point: Hyperthermia with radiation for chest wall recurrences.

Jones EL, Marks LB, Prosnitz LR.

J Natl Compr Canc Netw. 2007 Mar;5(3):339-44. Review.

PMID:
17439762
26.

Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate.

Anscher MS, Clough R, Robertson CN, Prosnitz LR, Dahm P, Walther P, Donatucci CF, Albala DM, Febbo P, George DJ, Sun L, Moul JW.

Prostate Cancer Prostatic Dis. 2006;9(3):254-60. Epub 2006 Aug 1.

PMID:
16880828
27.

Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma.

Jones E, Alvarez Secord A, Prosnitz LR, Samulski TV, Oleson JR, Berchuck A, Clarke-Pearson D, Soper J, Dewhirst MW, Vujaskovic Z.

Int J Hyperthermia. 2006 Mar;22(2):161-72.

PMID:
16754599
28.

Partial breast irradiation: a cautionary note.

Prosnitz LR, Marks LB.

Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):319-21. Epub 2006 Apr 3. No abstract available.

PMID:
16580790
29.

Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients.

Cheng SH, Horng CF, Clarke JL, Tsou MH, Tsai SY, Chen CM, Jian JJ, Liu MC, West M, Huang AT, Prosnitz LR.

Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1401-9. Epub 2006 Feb 10.

PMID:
16472935
30.

Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.

Koontz BF, Kirkpatrick JP, Clough RW, Prosnitz RG, Gockerman JP, Moore JO, Prosnitz LR.

J Clin Oncol. 2006 Feb 1;24(4):605-11.

PMID:
16446333
31.

Postmastectomy radiotherapy: quality counts!

Prosnitz LR, Marks LB.

J Natl Cancer Inst. 2006 Jan 4;98(1):3-4. No abstract available.

PMID:
16391361
32.

In regard to Vasanathan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153).

Jones EL, Prosnitz LR, Dewhirst MW, Vujaskovic Z, Samulski TV, Oleson JR, Yu D, Myerson RJ, Moros EG, Hurwitz MD, Bull JM.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):644. No abstract available.

PMID:
16168856
33.

Prospective assessment of quality of life in ovarian cancer patients receiving whole abdomen hyperthermia and liposomal doxorubicin.

Hahn CA, Jones EL, Blivin JL, Sanders LL, Yu D, Dewhirst MW, Secord AA, Prosnitz LR.

Int J Hyperthermia. 2005 Jun;21(4):349-57.

PMID:
16019860
34.

Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer.

Alvarez Secord A, Jones EL, Hahn CA, Petros WP, Yu D, Havrilesky LJ, Soper JT, Berchuck A, Spasojevic I, Clarke-Pearson DL, Prosnitz LR, Dewhirst MW.

Int J Hyperthermia. 2005 Jun;21(4):333-47.

PMID:
16019859
35.

First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma.

Westermann AM, Jones EL, Schem BC, van der Steen-Banasik EM, Koper P, Mella O, Uitterhoeve AL, de Wit R, van der Velden J, Burger C, van der Wilt CL, Dahl O, Prosnitz LR, van der Zee J.

Cancer. 2005 Aug 15;104(4):763-70.

36.

Randomized trial of hyperthermia and radiation for superficial tumors.

Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, Sanders LL, Dewhirst MW.

J Clin Oncol. 2005 May 1;23(13):3079-85.

PMID:
15860867
37.

Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy.

Dewhirst MW, Poulson JM, Yu D, Sanders L, Lora-Michiels M, Vujaskovic Z, Jones EL, Samulski TV, Powers BE, Brizel DM, Prosnitz LR, Charles HC.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):480-91.

PMID:
15667971
38.

Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer.

Jones EL, Prosnitz LR, Dewhirst MW, Marcom PK, Hardenbergh PH, Marks LB, Brizel DM, Vujaskovic Z.

Clin Cancer Res. 2004 Jul 1;10(13):4287-93.

39.

Data on sentinel lymph node metastases in ductal carcinoma in situ.

Prosnitz LR.

J Natl Compr Canc Netw. 2004 Jan;2(1):3; author reply 3-4. No abstract available.

PMID:
19777691
40.

Rituximab in lymphocyte predominance Hodgkin's disease: a case series.

Ibom VK, Prosnitz RG, Gong JZ, Moore JO, DeCastro CM, Prosnitz LR, Rizzieri DA, Gockerman JP.

Clin Lymphoma. 2003 Sep;4(2):115-8.

PMID:
14556684
41.

Ultrasound guided pO2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment.

Vujaskovic Z, Rosen EL, Blackwell KL, Jones EL, Brizel DM, Prosnitz LR, Samulski TV, Dewhirst MW.

Int J Hyperthermia. 2003 Sep-Oct;19(5):498-506.

PMID:
12944165
42.

A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma.

Jones EL, Samulski TV, Dewhirst MW, Alvarez-Secord A, Berchuck A, Clarke-Pearson D, Havrilesky LJ, Soper J, Prosnitz LR.

Cancer. 2003 Jul 15;98(2):277-82.

43.

Consolidation radiotherapy in the treatment of advanced Hodgkin's disease: is it dead?

Prosnitz LR.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):605-8. No abstract available.

PMID:
12788163
44.

Breast conservation rates-barriers between tertiary care and community practice.

Hahn CA, Marks LB, Chen DY, Lind PA, Lind HM, Prosnitz LR.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1196-9.

PMID:
12654427
45.

Optimizing combined modality therapy for Hodgkin's disease.

Prosnitz LR.

Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):1-2. No abstract available.

PMID:
12504028
46.

Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.

Lind PA, Marks LB, Jamieson TA, Carter DL, Vredenburgh JJ, Folz RJ, Prosnitz LR.

Cancer. 2002 Jun 1;94(11):2821-9. Review.

48.

Technical factors associated with radiation pneumonitis after local +/- regional radiation therapy for breast cancer.

Lind PA, Marks LB, Hardenbergh PH, Clough R, Fan M, Hollis D, Hernando ML, Lucas D, Piepgrass A, Prosnitz LR.

Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):137-43.

PMID:
11777631
49.

A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy.

Maguire PD, Samulski TV, Prosnitz LR, Jones EL, Rosner GL, Powers B, Layfield LW, Brizel DM, Scully SP, Harrelson JM, Dewhirst MW.

Int J Hyperthermia. 2001 Jul-Aug;17(4):283-90.

PMID:
11471980
50.

A practical and easy method to locate the first three internal mammary lymph node-bearing areas.

Marks LB, Bentel GC, Hardenbergh PH, Lind PA, Prosnitz LR.

Int J Radiat Oncol Biol Phys. 2001 Jun 1;50(2):421-5.

PMID:
11380229

Supplemental Content

Loading ...
Support Center